Nav: Home

UC researchers examine potential drug pathway to combat pneumocystis

December 14, 2016

CINCINNATI--A study led by University of Cincinnati (UC) researchers is offering new insight in how the fungus Pneumocystis, thrives in the lungs of immune-compromised individuals, where it can cause a fatal pneumonia.

The study, "Functional characterization of the Pneumocystis carinii Inositol Transporter 1," is currently available in the online edition of the journal, MBio and details the use of mouse models to identify a new drug therapy for the potential treatment of Pneumocystis pneumonia.

Pneumocystis must transport inositol--a sugar-like nutrient essential for life in most organisms--obtained from the mammalian lung using a specific transporter, explains Melanie T. Cushion, PhD, senior associate dean for research and professor of internal medicine at the UC College of Medicine.

"Identifying a drug to inhibit the transporter will kill these fungi because they can't synthesize inositol as they lack two enzymes to do so," says Cushion. "The transporters in humans and Pneumocystis are sufficiently different that inhibitors of the fungal transporter are not likely to impact the mammalian transporters. If that's the case, no toxicity is expected with this new line of drugs."

These fungi are immune to common current anti-fungal therapies, and the gold standard therapy, trimethoprim sulfamethoxazole, often results in life-threatening allergic reactions in many patients. In the journal article, researchers characterized the transport of inositol in the fungus and found that it was highly selective for inositol and did not transport any other molecules, explains Cushion.

For individuals living with HIV/AIDS, Pneumocystis jirovecii, causes a lethal pneumonia (PCP) despite the use of combined antiretroviral therapy in patients, says Cushion. The mortality rate from PCP is about 15 percent in HIV positive populations in the United States and other developed countries, while in the developing world or underserved populations in the U.S. the mortality rate approaches 80 percent, she explained.

An advance in combating Pneumocystis could also help transplant patients who are on immunosuppressive drugs for life and other patients receiving these therapies for ailments such as rheumatoid arthritis, says Cushion.
-end-
Cushion is joined in this research by co-authors Aleksey Porollo, PhD, UC assistant professor in the Department of Environmental Health and a researcher for Cincinnati Children's Medical Center; Edward Merino, PhD, UC associate professor in the Department of Chemistry; Anish Kizhakkekkara Vadukoot, PhD, a former UC post-doctoral fellow; Margaret Collins, senior research assistant in the UC Department of Internal Medicine; and Thomas Sesterhenn, senior research assistant in the UC Department of Internal Medicine.

Research reported in this publication was supported by the National Heart, Lung and Blood Institute, National Institutes of Health under the award number HL119190 and by the U.S. Department of Veterans Affairs. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

University of Cincinnati Academic Health Center

Related Fungus Articles:

Researchers look to fungus to shed light on cancer
A team of Florida State University researchers from the Department of Chemistry and Biochemistry found that a natural product from the fungus Fusicoccum amygdali stabilizes a family of proteins in the cell that mediate important signaling pathways involved in the pathology of cancer and neurological diseases.
The invisibility cloak of a fungus
The human immune system can easily recognize fungi because their cells are surrounded by a solid cell wall of chitin and other complex sugars.
Taming the wild cheese fungus
The flavors of fermented foods are heavily shaped by the fungi that grow on them, but the evolutionary origins of those fungi aren't well understood.
Candida auris is a new drug-resistant fungus emerging globally and in the US early detection is key to controlling spread of deadly drug-resistant fungus
Early identification of Candida auris, a potentially deadly fungus that causes bloodstream and intra-abdominal infections, is the key to controlling its spread.
Genetic blueprint for extraordinary wood-munching fungus
The first time someone took note of Coniochaeta pulveracea was more than two hundred years ago, when the South African-born mycologist Dr Christiaan Hendrik Persoon mentioned it in his 1797 book on the classification of fungi.
How a fungus can cripple the immune system
An international research team led by Professor Oliver Werz of Friedrich Schiller University, Jena, has now discovered how the fungus knocks out the immune defenses, enabling a potentially fatal fungal infection to develop.
North American checklist identifies the fungus among us
Some fungi are smelly and coated in mucus. Others have gills that glow in the dark.
Tropical frogs found to coexist with deadly fungus
In 2004, the frogs of El Copé, Panama, began dying by the thousands.
Deadly amphibian fungus has its origins in East Asia
The fungus kills frogs, toads and salamanders, and now we know where it emerged.
How wheat can root out the take-all fungus
In the soils of the world's cereal fields, a family tussle between related species of fungi is underway for control of the crops' roots, with food security on the line.
More Fungus News and Fungus Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.